Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
The Journal of Infectious Diseases|December 31, 2009
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) studySigne Westring Worm, Caroline Sabin, Rainer Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North AmericaEnrico Girardi, Caroline A Sabin, Antonella d'Arminio Monforte, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
AIDS (London, England)|January 8, 2013
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease eventsAntonella d'Arminio Monforte, Peter Reiss, Lene Ryom, et al.
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
AIDS (London, England)|June 24, 2003
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD studyNina Friis-Møller, Rainer Weber, Peter Reiss, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|June 3, 2011
Elevated triglycerides and risk of myocardial infarction in HIV-positive personsSigne W Worm, David A Kamara, Peter Reiss, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
The Journal of Infectious Diseases|December 31, 2009
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) studySigne Westring Worm, Caroline Sabin, Rainer Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North AmericaEnrico Girardi, Caroline A Sabin, Antonella d'Arminio Monforte, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
AIDS (London, England)|January 8, 2013
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease eventsAntonella d'Arminio Monforte, Peter Reiss, Lene Ryom, et al.
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
AIDS (London, England)|June 24, 2003
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD studyNina Friis-Møller, Rainer Weber, Peter Reiss, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|June 3, 2011
Elevated triglycerides and risk of myocardial infarction in HIV-positive personsSigne W Worm, David A Kamara, Peter Reiss, et al.
Pageof 18